Liquidia Corporation (LQDA) vs Nurix Therapeutics, Inc. (NRIX)

A side-by-side comparison of Liquidia Corporation and Nurix Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — LQDA vs NRIX

growth of $100 · dividends reinvested · last 6y
LQDA +356.1% (+28.8%/yr)NRIX +20.4% (+3.1%/yr)LQDA compounded faster over this window
05001k2kStart $100202120222023202420252026$456$120
LQDA NRIX

LQDA vs NRIX: by the numbers

  • •NRIX is the larger company ($2.34B vs $2.34B market cap).
  • •LQDA is profitable (30.74% net margin) while NRIX runs a net loss (-928.44%).
  • •LQDA grew revenue faster over the past five years (128.77% vs 9.96% CAGR).

Metrics side by side

Valuation

MetricLQDANRIX
P/E ratio19.22N/A
Forward P/E10.59N/A
P/S ratio5.1963.66
P/B ratio11.995.81
EV / EBITDA12.83N/A
FCF yield2.59%N/A

Profitability

MetricLQDANRIX
Gross margin92.48%77.55%
Operating margin-32.45%-340.16%
Net margin30.74%-928.44%
ROE71.04%-84.78%
ROIC46.99%-77.92%

Growth (annualized)

MetricLQDANRIX
Revenue CAGR (5Y)128.77%9.96%
Total return CAGR (5Y)59.01%-5.51%

Frequently asked

Which has grown faster, LQDA or NRIX?
Over the past five years, LQDA grew revenue faster — LQDA at a 128.77% CAGR versus NRIX at 9.96%.
Is LQDA or NRIX more profitable?
LQDA runs the higher net margin — LQDA at 30.74% versus NRIX at -928.44%.
How have LQDA and NRIX total returns compared?
Over the past 5 years, LQDA delivered 59.01% and NRIX delivered -5.51% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.